ERAMET Balance Sheet Health
Financial Health criteria checks 4/6
ERAMET has a total shareholder equity of €2.5B and total debt of €2.2B, which brings its debt-to-equity ratio to 89.8%. Its total assets and total liabilities are €6.8B and €4.3B respectively. ERAMET's EBIT is €16.0M making its interest coverage ratio 0.1. It has cash and short-term investments of €1.6B.
Key information
89.8%
Debt to equity ratio
€2.21b
Debt
| Interest coverage ratio | 0.1x |
| Cash | €1.59b |
| Equity | €2.46b |
| Total liabilities | €4.34b |
| Total assets | €6.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ER7's short term assets (€3.1B) exceed its short term liabilities (€1.5B).
Long Term Liabilities: ER7's short term assets (€3.1B) exceed its long term liabilities (€2.9B).
Debt to Equity History and Analysis
Debt Level: ER7's net debt to equity ratio (25%) is considered satisfactory.
Reducing Debt: ER7's debt to equity ratio has reduced from 110.8% to 89.8% over the past 5 years.
Debt Coverage: ER7's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: ER7's interest payments on its debt are not well covered by EBIT (0.1x coverage).